Selah Genomics

Selah Genomics provides a suite of services focused on support of molecular biomarker discovery, assay validation and prospective/retrospective clinical trial testing in support of companion diagnostic development and commercialization. Selah operates NGS platforms from Life Technologies, Illumina, Roche and PacBio as well as an array of real time PCR and other supporting instrumentation systems. We help you select the best platform for each Project in support of your particular goals. Our prime focus - to help fast-track the clinical utilization and commercialization of your biomarker.

The Clinical Laboratory at Selah Genomics supports healthcare providers with advanced molecular testing services from its CLIA-certified facility in Greenville, SC. Our domain expertise is coupled with a rapidly growing portfolio of molecular assays using traditional and cutting edge technologies. These advanced services provide the essential information that clinicians and healthcare providers need to deliver more personalized treatment and patient monitoring that lead to improved patient outcomes.

Selah's PrecisionPath™ service incorporates a range of clinically validated biomarker assays to support stratification and management of patients diagnosed with cancer. This service commenced in April 2013 and is now piloting at Greenville Health System's Institute of Translational Oncology Research (GHS ITOR). Knowledge of tumor biomarkers empowers the design of treatment plans for specific cancer types; treatment options can be tailored according to information the tumor is providing. In addition, Selah works with ITOR's oncologists to closely monitor data from recent high quality publications by the world's top researchers to further inform clinicians of emerging evidence in the field.